143 related articles for article (PubMed ID: 33261548)
1. Calcium Carbonate Microparticles as Carriers of
Li RG; Napoli E; Jorstad IS; Bønsdorff TB; Juzeniene A; Bruland ØS; Larsen RH; Westrøm S
Curr Radiopharm; 2021; 14(2):145-153. PubMed ID: 33261548
[TBL] [Abstract][Full Text] [Related]
2. Radon-220 diffusion from 224Ra-labeled calcium carbonate microparticles: Some implications for radiotherapeutic use.
Napoli E; Bønsdorff TB; Jorstad IS; Bruland ØS; Larsen RH; Westrøm S
PLoS One; 2021; 16(3):e0248133. PubMed ID: 33662039
[TBL] [Abstract][Full Text] [Related]
3. Ra-224 labeling of calcium carbonate microparticles for internal α-therapy: Preparation, stability, and biodistribution in mice.
Westrøm S; Malenge M; Jorstad IS; Napoli E; Bruland ØS; Bønsdorff TB; Larsen RH
J Labelled Comp Radiopharm; 2018 May; 61(6):472-486. PubMed ID: 29380410
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Effect of α-Emitting
Westrøm S; Bønsdorff TB; Bruland ØS; Larsen RH
Transl Oncol; 2018 Apr; 11(2):259-267. PubMed ID: 29413758
[TBL] [Abstract][Full Text] [Related]
5. Improved Formulation of
Li RG; Lindland K; Tonstad SK; Bønsdorff TB; Juzeniene A; Westrøm S; Larsen RH
Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33946852
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal alpha therapy with
Wouters R; Westrøm S; Berckmans Y; Riva M; Ceusters J; Bønsdorff TB; Vergote I; Coosemans A
Front Med (Lausanne); 2022; 9():995325. PubMed ID: 36300186
[TBL] [Abstract][Full Text] [Related]
7. Antitumor Activity of Novel Bone-seeking, α-emitting
Juzeniene A; Bernoulli J; Suominen M; Halleen J; Larsen RH
Anticancer Res; 2018 Apr; 38(4):1947-1955. PubMed ID: 29599310
[TBL] [Abstract][Full Text] [Related]
8. A Novel Single-Step-Labeled
Li RG; Lindland K; Bønsdorff TB; Westrøm S; Larsen RH
Materials (Basel); 2021 Nov; 14(23):. PubMed ID: 34885283
[TBL] [Abstract][Full Text] [Related]
9. Targeted alpha therapy with 227Th-trastuzumab of intraperitoneal ovarian cancer in nude mice.
Heyerdahl H; Abbas N; Sponheim K; Mollatt C; Bruland Ø; Dahle J
Curr Radiopharm; 2013 Jun; 6(2):106-16. PubMed ID: 23551111
[TBL] [Abstract][Full Text] [Related]
10. Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis.
Grønningsæter SR; Blakkisrud J; Selboe S; Revheim ME; Bruland ØS; Bønsdorff TB; Larsen SG; Stokke C
Front Med (Lausanne); 2023; 10():1058914. PubMed ID: 36844217
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
[TBL] [Abstract][Full Text] [Related]
12. Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model.
Henriksen G; Breistøl K; Bruland ØS; Fodstad Ø; Larsen RH
Cancer Res; 2002 Jun; 62(11):3120-5. PubMed ID: 12036923
[TBL] [Abstract][Full Text] [Related]
13. Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers.
Hagemann UB; Ellingsen C; Schuhmacher J; Kristian A; Mobergslien A; Cruciani V; Wickstroem K; Schatz CA; Kneip C; Golfier S; Smeets R; Uran S; Hennekes H; Karlsson J; Bjerke RM; Ryan OB; Mumberg D; Ziegelbauer K; Cuthbertson AS
Clin Cancer Res; 2019 Aug; 25(15):4723-4734. PubMed ID: 31064781
[TBL] [Abstract][Full Text] [Related]
14. Size-dependent therapeutic efficiency of
Akhmetova DR; Mitusova KA; Postovalova AS; Ivkina AS; Muslimov AR; Zyuzin MV; Shipilovskikh SA; Timin AS
Biomater Sci; 2024 Jan; 12(2):453-467. PubMed ID: 38059526
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2--a phase I study.
Andersson H; Cederkrantz E; Bäck T; Divgi C; Elgqvist J; Himmelman J; Horvath G; Jacobsson L; Jensen H; Lindegren S; Palm S; Hultborn R
J Nucl Med; 2009 Jul; 50(7):1153-60. PubMed ID: 19525452
[TBL] [Abstract][Full Text] [Related]
16. [
Yang Y; Alencar LMR; Pijeira MSO; Batista BDS; França ARS; Rates ERD; Lima RC; Gemini-Piperni S; Santos-Oliveira R
Drug Deliv; 2022 Dec; 29(1):186-191. PubMed ID: 35191342
[TBL] [Abstract][Full Text] [Related]
17. Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab')2: therapeutic efficacy and myelotoxicity.
Elgqvist J; Andersson H; Bäck T; Claesson I; Hultborn R; Jensen H; Lindegren S; Olsson M; Palm S; Warnhammar E; Jacobsson L
Nucl Med Biol; 2006 Nov; 33(8):1065-72. PubMed ID: 17127181
[TBL] [Abstract][Full Text] [Related]
18. Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results.
Trencsényi G; Csikos C; Képes Z
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203834
[TBL] [Abstract][Full Text] [Related]
19. Local control of lung derived tumors by diffusing alpha-emitting atoms released from intratumoral wires loaded with radium-224.
Cooks T; Schmidt M; Bittan H; Lazarov E; Arazi L; Kelson I; Keisari Y
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):966-73. PubMed ID: 19480976
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer.
Andersson H; Palm S; Lindegren S; Bäck T; Jacobsson L; Leser G; Horvath G
Anticancer Res; 2001; 21(1A):409-12. PubMed ID: 11299770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
